Jagsonpal Pharmaceuticals informs about annual secretarial compliance report

01 Jul 2020 Evaluate

Pursuant to Regulation 24A of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 read with SEBI Circular No. CIR/CFD/CMD1//27/2019 dated February 8, 2019, Jagsonpal Pharmaceuticals has informed that it has enclosed the Annual Secretarial Compliance Report for the Financial Year ended 31st March, 2020.

The above information is a part of company’s filings submitted to BSE. 

Jagsonpal Pharma Share Price

201.60 1.90 (0.95%)
16-Dec-2025 10:04 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1781.00
Dr. Reddys Lab 1274.60
Cipla 1502.10
Zydus Lifesciences 923.90
Lupin 2089.75
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×